Getting the message right will help the public reduce their risk of mental illness
In the 2006–07 budget, the Australian Government announced expenditure of $21.6 million over 4 years to improve community awareness of the link between using illicit drugs and the development of mental disorders. Community awareness programs to reduce the prevalence of unhealthy behaviours are nothing new; they have been around for decades for cancer, heart disease and infectious diseases. While campaigns focusing on the negative effects of drug misuse have already been delivered, this initiative breaks new ground. It will be the first large-scale campaign in Australia to tell the public what actions they can take to reduce their risk of developing mental disorders. Australia is not alone in this area, with both France and the United States launching campaigns in 2005 to alert the public to the potential link.1,2 However, it is too early to know whether these campaigns have had any effect.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Mission Interministerielle de Lutte Contre la Drogue et la Toxicomanie. (Interdepartmental Mission for the Fight against Drugs and Drug Addiction). http://www.drogues.gouv.fr/rubrique2.html (accessed Jun 2006).
- 2. Office of National Drug Control Policy. National youth anti-drug media campaign. White House Drug Czar, research and mental health communities warn parents that marijuana use can lead to depression, suicidal thoughts and schizophrenia [press release]. http://www.mediacampaign.org/newsroom/press05/050305.html (accessed Jun 2006).
- 3. Macleod J, Oakes R, Copello A, et al. Psychosocial and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 2004; 363: 1579-1588.
- 4. Arseneault L, Cannon M, Witton J, Murray RM. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 2004; 184: 110-117.
- 5. Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 2005; 57: 1117-1127.
- 6. Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression. Addiction 2003; 98: 1493-1504.
- 7. McKetin R, McLaren J, Lubman DI, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006; 101: 1473-1478.
- 8. Curran C, Byrappa N, McBride A. Stimulant psychosis: systematic review. Br J Psychiatry 2004; 185: 196-204.
- 9. Noar SM. A 10-year retrospective of research in health mass media campaigns: where do we go from here? J Health Commun 2006; 11: 21-42.
- 10. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot 1997; 12: 38-48.
- 11. Godin G, Kok G. The theory of planned behavior: a review of its applications to health-related behaviors. Am J Health Promot 1996; 11: 87-98.
- 12. Jorm AF, Griffiths KM. Population promotion of informal self-help strategies for early intervention against depression and anxiety. Psychol Med 2006; 36: 3-6.
Anthony Jorm is a member of the Expert Panel advising the Tasmanian Illicit Drugs and Mental Illness Awareness Campaign.